IA
PAHC icon

IFP Advisors’s Phibro Animal Health PAHC Stock Holding History

IFP Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$75 – 5119
2025
Q4 		$75 Hold
2
– – ﹤0.01% 4650
2025
Q3 		$81 Buy
+2
New +$66 ﹤0.01% 4577
2025
Q2 		– Hold
0
– – – 3996
2025
Q1 		– Sell
-13
Closed -$273 – 4549
2024
Q4 		$273 Buy
+13
New +$301 ﹤0.01% 3600
2023
Q1 		– Sell
-66
Closed -$4K – 4131
2022
Q4 		$4K Sell
66
-88
-57% -$1.18K ﹤0.01% 3922
2022
Q3 		$10K Buy
154
+28
+22% +$483 ﹤0.01% 3661
2022
Q2 		$7K Hold
126
– – ﹤0.01% 3615
2022
Q1 		$7K Buy
+126
New +$2.54K ﹤0.01% 3614
2018
Q2 		– Sell
-57
Closed -$2K – 4007
2018
Q1 		$2K Hold
57
– – ﹤0.01% 3526
2017
Q4 		$2K Hold
57
– – ﹤0.01% 3577
2017
Q3 		$2K Sell
57
-39
-41% -$1.47K ﹤0.01% 3770
2017
Q2 		$4K Buy
+96
New +$3.13K ﹤0.01% 3521

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

IFP Advisors's PAHC Position: Q1 2026 in Review

IFP Advisors sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 2 shares — an estimated $75 sold.

IFP Advisors first reported a position in PAHC in Q2 2017 and held it in 11 quarters. The position peaked at $10K in Q3 2022. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • IFP Advisors reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • IFP Advisors sold 2 Phibro Animal Health shares in Q1 2026, an estimated $75.
  • IFP Advisors first reported a position in Phibro Animal Health in Q2 2017 and held it in 11 quarters.
  • IFP Advisors's Phibro Animal Health position peaked at $10K in Q3 2022.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.